NIH-funded research R01 grant

Daily time-restricted eating to ease fatigue after blood cancers

Official title: Time-restricted eating to address cancer-related fatigue among survivors of hematological malignancies

Funded at University of Maryland Baltimore · NIH-11187059 · Data updated 2026-11-12

This project sees whether limiting eating to a 10-hour daytime window can help people who finished treatment for blood cancers feel less tired.

More Fatigue research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Maryland Baltimore
NIH-funded
Lab location1 site (Baltimore, United States)
Project startSeptember 6, 2024
Project endAugust 31, 2028
Funding year2025
Award (this year)$363,599
NIH project number5R01CA284082-02
Project IDNIH-11187059 on NIH RePORTER

Who could benefit from this research

Could help

Adults who completed curative treatment for hematologic (blood) cancers 2 months to 2 years ago, report moderate to severe fatigue, and currently eat across more than a 10-hour daily window.

Less likely to help

People still receiving cancer therapy, those with only mild fatigue, or those who already limit eating to about 10 hours or less are unlikely to benefit from this specific trial.

What this research studies

You would join a 12-week program where half of participants are asked to eat only during a consistent 10-hour daytime window while the other half continue their usual eating patterns. The study enrolls 96 survivors who are 2 months to 2 years past curative treatment and have moderate to severe fatigue. Researchers will use activity monitors and a phone app to track sleep, activity, and when you eat, with a follow-up visit planned at 24 weeks. Participation includes in-person visits at the study site and regular remote monitoring.

Why it matters

Potential benefit: If successful, this could offer a simple, non-drug way to reduce long-lasting fatigue after blood cancer treatment.

How similar studies have gone: Time-restricted eating has shown improvements in metabolism, sleep, and daily rhythms in other populations, but it is largely untested for cancer-related fatigue in blood cancer survivors.

Where this research is happening

  • University of Maryland Baltimore
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Kleckner, Amber Simmons — University of Maryland Baltimore
  • Study coordinator: Kleckner, Amber Simmons

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.